Poor diabetic control is associated with an increased risk of diabetic retinopathy, and there is a particularly increased risk in insulin-dependent (type 1) patients for the development of proliferative diabetic retinopathy.
the development of proliferative diabetic retinopathy.
There is good evidence that hyperperfusion is an impor tant factor in the evolution of diabetic retinopathy. This hyperperfusion is worse in those with poor diabetic con trol. The increased blood flow associated with high glu cose interferes with autoregulation , and this further increases flow, damaging the endothelial lining of the blood vessels and leading to worsening of the retinopathy.
There are over 800 publications in the world literature relating diabetic control to diabetic retinopathy. None of these suggests that good control is bad for diabetic ret inopathy, and there are only a few which indicate that ret inopathy is not related to the degree of diabetic control.
There are many problems with most of the studies: they are small, retrospective, not controlled, not randomised, and worst of all the assessment of the quality of control is not reliable. Until the late 1970s it was impossible to determine accurately the level of diabetic control In those on insulin, prevalence increased to levels similar to those in the young-onset patients, while those not treated by insulin had a lower level of retinopathy.
Proliferative retinopathy was also less common in these patients. A maximum of 40% of those on insulin had pro liferative lesions, and 20% of those not on insulin. There were a number of risk factors for the presence of ret inopathy and proliferative retinopathy. These included duration of diabetes, age of onset, raised blood pressure, worse diabetic control and albuminuria.
More interesting was the result of the 4-year follow-up examination, and the study of the relationship of diabetic control at baseline to the incidence, progression, and pro-gression to proliferative retinopathy in these patients. The patients were divided into quartiles on the basis of their HbAl level. In the young-onset patients the lowest quar tile had an incidence of retinopathy of 45%, while the highest had an incidence of over 80%. In the older-onset group on insulin the incidence was 40% and 50% respect ively, but the difference between the lower three groups was small. In those not on insulin the lowest quartile had an incidence of only 15%, compared with 50% in the high est quartile. Similar differences were present in the pro gression of retinopathy in those who already had retinal lesions at baseline. For the incidence of progression to proliferative retinopathy the greatest difference was in the young-onset patients: the lowest quartile had only a 1 % incidence of new proliferative lesions while in the highest quartile it was 24%.13.14 Klein felt that if the mean HbAI could be reduced by just 2% from its value of 11 % the incidence of new proliferative retinopathy would decrease by 50% in the whole group.
It therefore appears that poor diabetic control is bad for retinopathy. The question is why this is so. 
RETINAL BLOOD FLOW IN DIABETIC RETINOPATHY

WHY DOES THE INCREASED FLOW MATTER?
The 
